Exponent Surpasses €1 Billion Target with Fund V
Funding | Jul 09, 2025 | Exponent Private Equity

Exponent Private Equity, a prominent European private equity firm, announced the final close of its fifth fund, surpassing its target by 20% with commitments totaling over €1 billion. The Fund attracted strong backing from an international array of investors, including pension funds, endowments, and sovereign wealth funds. Exponent's strategy focuses on mid-market businesses across the UK, Ireland, and the Benelux, primarily investing in corporate, family, and founder-owned enterprises with the potential for profit doubling through revenue-driven growth. Exponent's Fund V has already made investments in Chanelle Pharma, Ethos Engineering, Kingsbridge Healthcare Group, and Hippo Digital, reinforcing their position as a trusted partner in the mid-market sector. The firm was aided in the fundraising process by Rede Partners LLP and Debevoise & Plimpton LLP.
Sectors
- Private Equity
- Pharmaceuticals
- Healthcare
- Technology
- Engineering and Construction
Geography
- Europe – Exponent Private Equity operates in the UK, Ireland, and Benelux, and the fund attracted European investors.
- North America – Fund V garnered investment interest from North American entities.
- Middle East – The fund received commitments from Middle Eastern investors.
- Asia – Asian investors are part of the globally diversified base supporting Fund V.
- Ireland – Investments in companies like Kingsbridge Healthcare Group and Ethos Engineering, with operations in Ireland, highlight regional relevance.
Industry
- Private Equity – Exponent Private Equity is involved, focusing primarily on mid-market businesses, showcasing activity in the private equity industry.
- Pharmaceuticals – Involvement through Exponent's investment in Chanelle Pharma, a European leader in generic and veterinary pharmaceuticals.
- Healthcare – Participation through Exponent's investment in Kingsbridge Healthcare Group, Northern Ireland's largest private healthcare provider.
- Technology – Related through Exponent's investment in Hippo Digital, a technology consultancy specializing in digital transformation.
- Engineering and Construction – Ethos Engineering, specializing in sustainable data centre design, represents Exponent's investment in the engineering sector.
Financials
- €1 billion – Total commitments raised for Fund V, exceeding the target.
- 20% – Percentage by which Fund V surpassed its fundraising target.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Exponent Private Equity | Private Equity Firm | Company | A leading European private equity firm behind Fund V. |
| Marius Østlie | Partner | Person | Partner at Exponent, responsible for commenting on the fund raise. |
| Richard Lenane | Managing Partner | Person | Managing Partner at Exponent, speaking on the differentiated strategy. |
| Rede Partners LLP | Fundraising Advisor | Company | Advised Exponent on the fundraise. |
| Debevoise & Plimpton LLP | Legal Counsel | Company | Served as legal counsel for Exponent's fundraising. |
| Chanelle Pharma | Portfolio Company | Company | A European leader in generic and veterinary pharmaceuticals. |
| Ethos Engineering | Portfolio Company | Company | Specialist in sustainable, mission-critical data centre design. |
| Kingsbridge Healthcare Group | Portfolio Company | Company | The largest private healthcare provider in Northern Ireland. |
| Hippo Digital | Portfolio Company | Company | Technology consultancy focused on user-centred digital transformation. |